Mission BioCapital, a venture fund based in Cambridge, Massachusetts, was founded in 2009 by Peter Parker. The fund focuses on investing in early-stage companies in the healthcare, medical device, nanotechnology, and biotech sectors. Mission BioCapital has made 56 investments and has seen 16 exits. Some of the portfolio companies include GraphWear Technologies, QurAlis, ViewPoint Therapeutics, and Shape Therapeutics. The fund invests in companies at the Pre-Seed, Seed, and Series A stages. For more information, visit their website at www.missionbiocapital.com.